Richard Kivel serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Richard Kivel has executed 3 insider transactions totaling $2.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 10, 2022 involved receiving (via award) 41,401 shares valued at $0.
Richard Kivel currently holds 41,401 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Kivel has been a net buyer of RNN stock. They have purchased $2.6K and sold $0 worth of shares.
Richard Kivel's most recent insider trade was on Jun 10, 2022, when they sold 41,401 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 3, 2011 | RNN | $2.6K | Purchase | 2,500 | $1.04 | Discretionary |